Theraclion SA (TCLIF)

OTCMKTS · Delayed Price · Currency is USD
0.320
+0.320 (159,900.00%)
At close: Aug 26, 2024
Market Cap 33.34M
Revenue (ttm) 2.20M
Net Income (ttm) -6.17M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 2,367
Open 0.320
Previous Close 0.000
Day's Range 0.320 - 0.320
52-Week Range 0.000 - 0.590
Beta -0.12
RSI n/a
Earnings Date Dec 23, 2025

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 32
Stock Exchange OTCMKTS
Ticker Symbol TCLIF
Full Company Profile

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.